5 November 2008
M.P. EVANS GROUP PLC ("M.P. EVANS" or the "Company")
Completion of acquisition
On 3 October 2008 it was announced that a conditional agreement had been reached
with Mr J D Shaw, a director of M.P. Evans, to acquire Sandlark Pty Limited
("Sandlark"), an Australian company owned by Mr Shaw and his wife, whose
principal asset is its holding of 302,607 shares in The North Australian
Pastoral Company Pty. Limited.
The purchase price for Sandlark was A$2,467,297 which was to be settled by way
of the issue to Mr and Mrs Shaw of 389,577 new M.P. Evans shares. The
transaction was subject to the approval of the Australian Foreign Investment
Review Board, which has now been granted.
Accordingly, application will be made to the London Stock Exchange plc for the
admission of 389,577 new shares to trading on AIM which is expected on
12 November 2008. Following the issue of the new shares, the Company's issued
share capital will consist of 52,101,585 shares of 10p each with voting rights.
For further information:
M.P. Evans Group PLC 01892 516333
Peter Hadsley-Chaplin, Joint Managing Director
Philip Fletcher, Joint Managing Director
Panmure Gordon 020 7459 3600
Edward Farmer
Rakesh Sharma
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.